Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Morgan

Showing results (31-40 of 120) with videos related to

Pageof 12
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|July 16, 2004
Amphetamine-induced chorea in attention deficit-hyperactivity disorderJohn C Morgan, W Christopher Winter, G Frederick Wooten
Current Neurology and Neuroscience Reports|June 12, 2009
Paraneoplastic movement disordersShyamal H Mehta, John C Morgan, Kapil D Sethi
Clinical Case Reports|August 15, 2015
Low-dose niacin supplementation modulates GPR109A, niacin index and ameliorates Parkinson's disease symptoms without side effectsChandramohan Wakade, Raymond Chong, Eric Bradley, et al.
Current Neurology and Neuroscience Reports|August 17, 2010
Does rasagiline have a disease-modifying effect on Parkinson's disease?Shyamal H Mehta, John C Morgan, Kapil D Sethi
Archives of Neurology|February 16, 2006
Impulse control disorders and dopaminergic drugsJohn C Morgan, Sanjay S Iyer, Kapil D Sethi
Neurologic Clinics|November 30, 2014
Drug-induced movement disordersShyamal H Mehta, John C Morgan, Kapil D Sethi
Neurology|November 9, 2005
Absorption of orally disintegrating carbidopa-levodopa requires intact small bowel functionSanjay S Iyer, John C Morgan, Kapil D Sethi
Neurology|June 9, 2004
Botulinum toxin treatment of painful tonic spasms in multiple sclerosisJohn C Morgan, David C Hess, Kapil D Sethi
CNS Spectrums|April 2, 2008
Sleep disorders associated with Parkinson's disease: role of dopamine, epidemiology, and clinical scales of assessmentShyamal H Mehta, John C Morgan, Kapil D Sethi
Clinical Neurology and Neurosurgery|April 20, 2006
Other causes of ataxia in patients with SCA mutationsSteven B Dawson, John C Morgan, Kapil D Sethi
Pageof 12

Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
Movement Disorders : Official Journal of the Movement Disorder Society|July 16, 2004
Amphetamine-induced chorea in attention deficit-hyperactivity disorderJohn C Morgan, W Christopher Winter, G Frederick Wooten
Current Neurology and Neuroscience Reports|June 12, 2009
Paraneoplastic movement disordersShyamal H Mehta, John C Morgan, Kapil D Sethi
Clinical Case Reports|August 15, 2015
Low-dose niacin supplementation modulates GPR109A, niacin index and ameliorates Parkinson's disease symptoms without side effectsChandramohan Wakade, Raymond Chong, Eric Bradley, et al.
Current Neurology and Neuroscience Reports|August 17, 2010
Does rasagiline have a disease-modifying effect on Parkinson's disease?Shyamal H Mehta, John C Morgan, Kapil D Sethi
Archives of Neurology|February 16, 2006
Impulse control disorders and dopaminergic drugsJohn C Morgan, Sanjay S Iyer, Kapil D Sethi
Neurologic Clinics|November 30, 2014
Drug-induced movement disordersShyamal H Mehta, John C Morgan, Kapil D Sethi
Neurology|November 9, 2005
Absorption of orally disintegrating carbidopa-levodopa requires intact small bowel functionSanjay S Iyer, John C Morgan, Kapil D Sethi
Neurology|June 9, 2004
Botulinum toxin treatment of painful tonic spasms in multiple sclerosisJohn C Morgan, David C Hess, Kapil D Sethi
CNS Spectrums|April 2, 2008
Sleep disorders associated with Parkinson's disease: role of dopamine, epidemiology, and clinical scales of assessmentShyamal H Mehta, John C Morgan, Kapil D Sethi
Clinical Neurology and Neurosurgery|April 20, 2006
Other causes of ataxia in patients with SCA mutationsSteven B Dawson, John C Morgan, Kapil D Sethi
Pageof 12